Mechanism of biochemical action of substituted 4-methylbenzopyran-2-ones. Part 10: Identification of inhibitors for the liver microsomal acetoxycoumarin: Protein transacetylase

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 6, 2003, Pages 1015-1019

  Raj, Hanumantharao G ^a   Singh, Ishwar ^b   Kohli, Ekta ^a   Kumari, Ranju ^a   Gupta, Garima ^a   Tyagi, Yogesh K ^a   Kumar, Ajit ^a   Prasad, Ashok K ^b   Kaushik, Narendra K ^b   Olsen, Carl E ^c   Watterson, Arthur C ^d   Parmar, Virinder S ^b,d  

^a UNIVERSITY OF DELHI   (India)

^b UNIVERSITY OF DELHI   (India)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d University of Massachusetts Lowell   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ACETOXY 2,3 DIHYDRO 2,2 DIMETHYLBENZOPYRAN; 7,8 DIACETOXY 4 METHYLCOUMARIN; ACETIC ACID DERIVATIVE; ACETOXYCOUMARIN; ACYLTRANSFERASE; AFLATOXIN B1; BENZOPYRAN DERIVATIVE; CETACHIN PENTAACETATE; COUMARIN DERIVATIVE; GLUTATHIONE TRANSFERASE; HEMATOXYLIN PENTAACETATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; LIVER MICROSOME; MALE; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT;

AFLATOXIN B1; ANIMALS; BENZOPYRANS; BINDING, COMPETITIVE; CYTOSOL; DNA; ENZYME INHIBITORS; MALE; MICROSOMES, LIVER; NADPH-FERRIHEMOPROTEIN REDUCTASE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; RATS, WISTAR; SUBSTRATE SPECIFICITY;

EID: 0037334228     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(02)00515-1     Document Type: Article

References (16)

1. Raj H.G., Parmar V.S., Jain S.C., Goel S., Singh A., Gupta K., Rohil V., Tyagi Y.K., Jha H.N., Olsen C.E., Wengel J. Bioorg. Med. Chem. 6:1998;1895.
2. Raj H.G., Parmar V.S., Jain S.C., Goel S., Singh A., Tyagi Y.K., Jha H.N., Olsen C.E., Wengel J. Bioorg. Med. Chem. 7:1999;369.
3. Raj H.G., Parmar V.S., Jain S.C., Kohli E., Ahmad N., Goel S., Tyagi Y.K., Sharma S.K., Wengel J., Olsen C.E. Bioorg. Med. Chem. 8:2000;1707.
4. Singh, I.; Kohli, E.; Raj, H. G.; Gyanda, K.; Jain, S. K.; Tyagi, Y. K.; Gupta, G.; Kumari, R.; Kumar, A.; Pal, G.; Prasad, A. K.; Rastogi, R. C.; Olsen, C. E.; Jain, S. C.; Parmar, V. S. Bioorg. Med. Chem. 2002, 10, 4103.
5. Parmar V.S., Bisht K.S., Jain R., Singh S., Sharma S.K., Gupta S., Malhotra S., Tyagi O.D., Vardhan A., Pati H.N., Vanden Berghe D., Vlietinck A.J. Indian J. Chem. 35B:1996;220.
6. Levai A., Timar T. Synthesis. 1990;339.
7. Morsingh F., Robinson R. Tetrahedron. 26:1970;281.
8. Lowry O.H., Rosebrough N.J., Farr A.K., Randall R.J. J. Biol. Chem. 193:1951;265.
9. Habig W.H., Pabst M.J., Jakoby W.B. J. Biol. Chem. 249:1974;7130.
10. Masters B.S.S., Billimoria M., Kamin H., Gibson Q.H. J. Biol. Chem. 240:1965;408.
11. Wang T.V., Cerutti P.A. Cancer Res. 39:1979;5165.
12. Allameh A., Saxena M., Raj H.G. Cancer Lett. 40:1988;49.
13. Raj H.G., Parmar V.S., Kohli E., Tyagi Y.K., Jain S.C., Olsen C.E. FASEB J. 14:2000;A1445.
14. Kohli E., Kumari R., Gupta G., Raj H.G., Parmar V.S., Ahmad N., Jain S.C., Pal G., Olsen C.E. Drug Metab. Rev. 33(Suppl. 1):2001;39.
15. Kumari R., Kohli E., Gupta G., Raj H.G., Parmar V.S., Pal G., Tyagi Y.K., Jain S.C., Olsen C.E. Placenta. 23:2002;352.
16. Copeland R.A. Enzymes: A Practical Introduction to Structure Mechanism and Data Analysis. 1996;VCH, Weinheim. pp. 201.